Jump to content

GLI3

From Wikipedia, the free encyclopedia
(Redirected from Gli3)
GLI3
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesGLI3, ACLS, GCPS, GLI3-190, GLI3FL, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV, GLI family zinc finger 3
External IDsOMIM: 165240; MGI: 95729; HomoloGene: 139; GeneCards: GLI3; OMA:GLI3 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000168

NM_008130

RefSeq (protein)

NP_000159

NP_032156

Location (UCSC)Chr 7: 41.96 – 42.26 MbChr 13: 15.64 – 15.9 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Zinc finger protein GLI3 is a protein that in humans is encoded by the GLI3 gene.[5][6]

This gene encodes a protein that belongs to the C2H2-type zinc finger proteins subclass of the Gli family. They are characterized as DNA-binding transcription factors and are mediators of Sonic hedgehog (Shh) signaling. The protein encoded by this gene localizes in the cytoplasm and activates patched Drosophila homolog (PTCH1) gene expression. It is also thought to play a role during embryogenesis.[6]

Role in development

[edit]

Gli3 is a known transcriptional repressor but may also have a positive transcriptional function.[7][8] Gli3 represses dHand and Gremlin, which are involved in developing digits.[9] There is evidence that Shh-controlled processing (e.g., cleavage) regulates transcriptional activity of Gli3 similarly to that of Ci.[8] Gli3 mutant mice have many abnormalities including CNS and lung defects and limb polydactyly.[10][11][12][13][14] In the developing mouse limb bud, Gli3 derepression predominantly regulates Shh target genes.[15]

Disease association

[edit]

Mutations in this gene have been associated with several diseases, including Greig cephalopolysyndactyly syndrome, Pallister–Hall syndrome, preaxial polydactyly type IV, and postaxial polydactyly types A1 and B.[6] DNA copy-number alterations that contribute to increased conversion of the oncogenes Gli1–3 into transcriptional activators by the Hedgehog signaling pathway are included in a genome-wide pattern, which was found to be correlated with an astrocytoma patient's outcome.[16][17]

There is evidence that the autosomal dominant disorder Greig cephalopolysyndactyly syndrome (GCPS) that affects limb and craniofacial development in humans is caused by a translocations within the GLI3 gene.[18]

Interactions with Gli1 and Gli2

[edit]

The independent overexpression Gli1 and Gli2 in mice models to lead to formation of basal cell carcinoma (BCC). Gli1 knockout is shown to lead to similar embryonic malformations as Gli1 overexpressions but not the formation of BCCs. Overexpression of Gli3 in transgenic mice and frogs does not lead to the development of BCC-like tumors and is not thought to play a role in tumor BCC formation.[19]

Gli1 and Gli2 overexpression leads to BCC formation in mouse models and a one step model for tumour formation has been suggested in both cases. This also indicates that Gli1 and/or Gli2 overexpression is vital in BCC formation. Co-overexpression of Gli1 with Gli2 and Gli2 with Gli3 leads to transgenic mice malformations and death, respectively, but not the formation of BCC. This suggests that overexpression of more than one Gli protein is not necessary for BCC formation.

Interactions

[edit]

GLI3 has been shown to interact with CREBBP[20] SUFU,[21] ZIC1,[22] and ZIC2.[22]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000106571Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000021318Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Ruppert JM, Vogelstein B, Arheden K, Kinzler KW (October 1990). "GLI3 encodes a 190-kilodalton protein with multiple regions of GLI similarity". Molecular and Cellular Biology. 10 (10): 5408–15. doi:10.1128/mcb.10.10.5408. PMC 361243. PMID 2118997.
  6. ^ a b c "Entrez Gene: GLI3 GLI-Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome)".
  7. ^ Taipale J, Beachy PA (May 2001). "The Hedgehog and Wnt signalling pathways in cancer". Nature. 411 (6835): 349–54. Bibcode:2001Natur.411..349T. doi:10.1038/35077219. PMID 11357142. S2CID 4414768.
  8. ^ a b Jacob J, Briscoe J (August 2003). "Gli proteins and the control of spinal-cord patterning". EMBO Reports. 4 (8): 761–5. doi:10.1038/sj.embor.embor896. PMC 1326336. PMID 12897799.
  9. ^ te Welscher P, Fernandez-Teran M, Ros MA, Zeller R (February 2002). "Mutual genetic antagonism involving GLI3 and dHAND prepatterns the vertebrate limb bud mesenchyme prior to SHH signaling". Genes & Development. 16 (4): 421–6. doi:10.1101/gad.219202. PMC 155343. PMID 11850405.
  10. ^ Rash BG, Grove EA (October 2007). "Patterning the dorsal telencephalon: a role for sonic hedgehog?". The Journal of Neuroscience. 27 (43): 11595–603. doi:10.1523/jneurosci.3204-07.2007. PMC 6673221. PMID 17959802.
  11. ^ Franz T (1994). "Extra-toes (Xt) homozygous mutant mice demonstrate a role for the Gli-3 gene in the development of the forebrain". Acta Anatomica. 150 (1): 38–44. doi:10.1159/000147600. PMID 7976186.
  12. ^ Grove EA, Tole S, Limon J, Yip L, Ragsdale CW (June 1998). "The hem of the embryonic cerebral cortex is defined by the expression of multiple Wnt genes and is compromised in Gli3-deficient mice". Development. 125 (12): 2315–25. doi:10.1242/dev.125.12.2315. PMID 9584130.
  13. ^ Hui CC, Joyner AL (March 1993). "A mouse model of greig cephalopolysyndactyly syndrome: the extra-toesJ mutation contains an intragenic deletion of the Gli3 gene". Nature Genetics. 3 (3): 241–6. doi:10.1038/ng0393-241. PMID 8387379. S2CID 345712.
  14. ^ Schimmang T, Lemaistre M, Vortkamp A, Rüther U (November 1992). "Expression of the zinc finger gene Gli3 is affected in the morphogenetic mouse mutant extra-toes (Xt)". Development. 116 (3): 799–804. doi:10.1242/dev.116.3.799. PMID 1289066.
  15. ^ Lewandowski JP, Du F, Zhang S, Powell MB, Falkenstein KN, Ji H, Vokes SA (Oct 2015). "Spatiotemporal regulation of GLI target genes in the mammalian limb bud". Dev. Biol. 406 (1): 92–103. doi:10.1016/j.ydbio.2015.07.022. PMC 4587286. PMID 26238476.
  16. ^ Aiello KA, Ponnapalli SP, Alter O (September 2018). "Mathematically universal and biologically consistent astrocytoma genotype encodes for transformation and predicts survival phenotype". APL Bioengineering. 2 (3): 031909. doi:10.1063/1.5037882. PMC 6215493. PMID 30397684.
  17. ^ Aiello KA, Alter O (October 2016). "Platform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral Decomposition". PLOS ONE. 11 (10): e0164546. Bibcode:2016PLoSO..1164546A. doi:10.1371/journal.pone.0164546. PMC 5087864. PMID 27798635.
  18. ^ Böse J, Grotewold L, Rüther U (May 2002). "Pallister-Hall syndrome phenotype in mice mutant for Gli3". Human Molecular Genetics. 11 (9): 1129–35. doi:10.1093/hmg/11.9.1129. PMID 11978771.
  19. ^ Dahmane N, Lee J, Robins P, Heller P, Ruiz i Altaba A (October 1997). "Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours". Nature. 389 (6653): 876–81. Bibcode:1997Natur.389..876D. doi:10.1038/39918. PMID 9349822. S2CID 4424572.
  20. ^ Dai P, Akimaru H, Tanaka Y, Maekawa T, Nakafuku M, Ishii S (March 1999). "Sonic Hedgehog-induced activation of the Gli1 promoter is mediated by GLI3". The Journal of Biological Chemistry. 274 (12): 8143–52. doi:10.1074/jbc.274.12.8143. PMID 10075717.
  21. ^ Humke EW, Dorn KV, Milenkovic L, Scott MP, Rohatgi R (April 2010). "The output of Hedgehog signaling is controlled by the dynamic association between Suppressor of Fused and the Gli proteins". Genes & Development. 24 (7): 670–82. doi:10.1101/gad.1902910. PMC 2849124. PMID 20360384.
  22. ^ a b Koyabu Y, Nakata K, Mizugishi K, Aruga J, Mikoshiba K (March 2001). "Physical and functional interactions between Zic and Gli proteins". The Journal of Biological Chemistry. 276 (10): 6889–92. doi:10.1074/jbc.C000773200. PMID 11238441.
[edit]

This article incorporates text from the United States National Library of Medicine, which is in the public domain.